On demand presentation
The landscape of emerging inflammatory diseases: lessons learnt from organoids
Modelling human inflammation "in a dish"
The lack of preclinical cellular models that recapitulate the human disease is a major setback in the study of non-oncogenic conditions with an inflammatory component. In this presentation Dr. Sylvia Boj, CSO at HUB will discuss:
- How HUB Organoid Technology has contributed to advancing our understanding of human inflammatory conditions such as Inflammatory Bowel Disease (IBD), Crohn’s Disease, Ulcerative Colitis, and COPD
- That HUB Organoids can be derived from non-transformed or non-malignant cells, therefore representing a unique opportunity for investigating therapeutic intervention